Cargando…
Excess Risk of Major Adverse Cardiovascular and Kidney Events after Acute Kidney Injury following Living Donor Liver Transplantation
Acute kidney injury (AKI) is a well-known risk factor for major adverse kidney events (MAKE) and major adverse cardiovascular events (MACE) in nontransplant settings. However, the association between AKI after liver transplantation (LT) and MACE/MAKE is not established. A retrospective cohort analys...
Autores principales: | Chan, Yi-Chia, Yeh, Cheng-Hsi, Li, Lung-Chih, Chen, Chao-Long, Wang, Chih-Chi, Lin, Chih-Chi, Ong, Aldwin D., Chiou, Ting-Yu, Yong, Chee-Chien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181469/ https://www.ncbi.nlm.nih.gov/pubmed/35683487 http://dx.doi.org/10.3390/jcm11113100 |
Ejemplares similares
-
Long-term renal outcomes comparison between patients with chronic kidney disease and hepatorenal syndrome after living donor liver transplantation
por: Tseng, Hsiang-Yu, et al.
Publicado: (2023) -
Can Microscopic Biliary Reconstruction Reduce Biliary Complication Rate in ABO-Incompatible Adult Living Donor Liver Transplantation?
por: Lin, Yu-Cheng, et al.
Publicado: (2021) -
Comparative Adverse Kidney Outcomes in Women Receiving Raloxifene and Denosumab in a Real-World Setting
por: Chen, Hsin-Wei, et al.
Publicado: (2022) -
Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients
por: Chiang, Heng-Yi, et al.
Publicado: (2023) -
AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation
por: Chen, I-Hsuan, et al.
Publicado: (2023)